PTC Therapeutics Management
How experienced are the management team and are they aligned to shareholders interests?
3.8yrs
Average management tenure
CEO
Stuart Peltz (62 yo)
25yrs
Tenure
US$11,022,323
Compensation
Dr. Stuart W. Peltz, Ph D., co-founded PTC Therapeutics Inc. in 1998 and has been its Chief Executive Officer since 1998. Dr. Peltz has been Independent Director of Health Sciences Acquisitions Corporation...
CEO Compensation Analysis
| Date | Total Comp. | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$531m |
| Jun 30 2022 | n/a | n/a | -US$556m |
| Mar 31 2022 | n/a | n/a | -US$522m |
| Dec 31 2021 | US$11m | US$769k | -US$524m |
| Sep 30 2021 | n/a | n/a | -US$455m |
| Jun 30 2021 | n/a | n/a | -US$391m |
| Mar 31 2021 | n/a | n/a | -US$454m |
| Dec 31 2020 | US$11m | US$742k | -US$438m |
| Sep 30 2020 | n/a | n/a | -US$441m |
| Jun 30 2020 | n/a | n/a | -US$432m |
| Mar 31 2020 | n/a | n/a | -US$292m |
| Dec 31 2019 | US$8m | US$702k | -US$252m |
| Sep 30 2019 | n/a | n/a | -US$222m |
| Jun 30 2019 | n/a | n/a | -US$213m |
| Mar 31 2019 | n/a | n/a | -US$181m |
| Dec 31 2018 | US$4m | US$659k | -US$128m |
| Sep 30 2018 | n/a | n/a | -US$78m |
| Jun 30 2018 | n/a | n/a | -US$61m |
| Mar 31 2018 | n/a | n/a | -US$69m |
| Dec 31 2017 | US$2m | US$637k | -US$79m |
| Sep 30 2017 | n/a | n/a | -US$107m |
| Jun 30 2017 | n/a | n/a | -US$108m |
| Mar 31 2017 | n/a | n/a | -US$130m |
| Dec 31 2016 | US$4m | US$618k | -US$142m |
Compensation vs Market: Stuart's total compensation ($USD11.02M) is above average for companies of similar size in the US market ($USD6.52M).
Compensation vs Earnings: Stuart's compensation has increased whilst the company is unprofitable.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 25yrs | US$11.02m | 0.093% $ 3.1m | |
| Co-Founder | 25yrs | US$721.21k | 0.0089% $ 298.1k | |
| Chief Financial Officer | 3.58yrs | US$4.49m | 0.065% $ 2.2m | |
| Chief Technical Operations Officer | 4.08yrs | US$4.28m | 0.038% $ 1.3m | |
| Executive VP & Chief Legal Officer | 10.83yrs | US$4.29m | 0.052% $ 1.8m | |
| Chief Business Officer | 7.75yrs | US$4.28m | 0.032% $ 1.1m | |
| Advisor | 0.083yr | US$640.71k | 0.037% $ 1.2m | |
| Chief Operating Officer | 1yr | no data | 0.023% $ 763.7k | |
| Senior VP | 3.58yrs | US$1.70m | 0.032% $ 1.1m | |
| Chief Scientific Officer | 1.67yrs | no data | no data | |
| Investor Relations Officer | no data | no data | no data | |
| Vice President of Corporate Communications | no data | no data | no data |
3.8yrs
Average Tenure
61yo
Average Age
Experienced Management: PTCT's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 25yrs | US$11.02m | 0.093% $ 3.1m | |
| Co-Founder | 25yrs | US$721.21k | 0.0089% $ 298.1k | |
| Independent Chairman of the Board | 21.42yrs | US$1.24m | 2.04% $ 68.5m | |
| Independent Director | 17.08yrs | US$650.71k | 0.0063% $ 213.2k | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 10.33yrs | US$633.71k | 0.0041% $ 137.3k | |
| Independent Director | 4.08yrs | US$653.71k | 0.0078% $ 260.5k | |
| Member of Scientific Advisory Board | 19.17yrs | no data | no data | |
| Independent Director | 7.58yrs | US$638.71k | 0.0041% $ 137.3k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.08yrs | US$633.71k | 0% $ 0 |
17.1yrs
Average Tenure
62yo
Average Age
Experienced Board: PTCT's board of directors are seasoned and experienced ( 17.1 years average tenure).